ORIC
NASDAQ · Biotechnology
Oric Pharmaceuticals Inc
$8.82
+0.33 (+3.89%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Price Target
Analyst Price Target
+492.5% upside
Low Target
$31.55
Average Target
$52.26
High Target
$71.26
Current Price
$8.82
Current
$8.82
$8.82
Target
$52.26
$52.26
$31.55
$52.26 avg
$71.26
Scenario Analysis
Bear Case
$31.55
257.7%
Low target
Base Case
$52.26
+492.5%
Avg target
Bull Case
$71.26
+707.9%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$14.68
-39.9% from high
52-Week Low
$7.23
+22.0% from low
Target vs 52W High
$52.26
+256.0% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.40
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |